Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH) (EAS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01784562
Expanded Access Status : No longer available
First Posted : February 6, 2013
Last Update Posted : January 6, 2016
Information provided by (Responsible Party):